A monoclonal antibody directed against a conformational epitope of the HIV-1 trans-activator (Tat) protein neutralizes cross-clade.

The Journal of Biological Chemistry
Sonia MediouniGilbert Baillat

Abstract

The identification of a neutralizing mAb against extracellular HIV-1 transactivator of transcription (Tat) is important for the development of an efficient HIV-1 treatment. Tat plays an essential role in HIV-1 pathogenesis, not only for HIV-1 replication but also as an extracellular toxin able to disrupt the immune system. We showed previously that immunization of rabbits with Tat Oyi, a variant cloned from an African woman who did not develop AIDS following HIV-1 infection, raised antibodies able to recognize different Tat variants. We carried out mice immunization with Tat Oyi and selected a mAb named 7G12, which had the capacity to cross-recognize heterologous Tat variants by a common three-dimensional epitope. These results highlighted that Tat variants were able to acquire a structure, in contrast to a number of studies showing Tat as an unfolded protein. mAb 7G12 also had the capacity to neutralize the biological activities of these Tat variants by blocking the cellular uptake of extracellular Tat. This is the first study using Tat Oyi to produce a mAb able to neutralize effectively activities of extracellular Tats from different HIV-1 subtypes. This mAb has an important potential in therapeutic passive immunization and c...Continue Reading

References

Oct 3, 1985·Nature·F Wong-Staal, R C Gallo
Dec 1, 1995·Journal of Acquired Immune Deficiency Syndromes and Human Retrovirology : Official Publication of the International Retrovirology Association·M C ReM La Placa
Jan 1, 1994·Archives of Virology·L SteinaaJ E Hansen
May 1, 1996·AIDS Research and Human Retroviruses·H ValvatneD E Helland
Jun 1, 1997·Journal of Virological Methods·S E FongS R Jaskunas
May 9, 2002·Proceedings of the National Academy of Sciences of the United States of America·Maxime MoulardDimiter S Dimitrov
Jun 25, 2002·The Journal of Biological Chemistry·Sandrine OpiErwann P Loret
May 27, 2003·Nature Reviews. Immunology·Marie-Lise Gougeon
Feb 5, 2005·Retrovirology·Jean de MareuilErwann P Loret
Sep 13, 2005·The Journal of Biological Chemistry·Grant R CampbellStephen A Spector
Jun 15, 2007·Journal of Virology·Amapola ManriqueAlexandra Trkola
Nov 30, 2007·Current HIV Research·Victor G KramerRuth M Ruprecht
Sep 24, 2008·Retrovirology·Jennifer D WatkinsErwann P Loret
Feb 10, 2011·Infectious Disorders Drug Targets·Sonia MediouniErwann Loret
Aug 11, 2011·AIDS Research and Human Retroviruses·Weizao Chen, Dimiter S Dimitrov

❮ Previous
Next ❯

Citations

Nov 12, 2013·Talanta·Pavithra JanardhananShuowei Cai
Jan 1, 2012·Biology·Guillaume Mousseau, Susana Valente
Mar 22, 2018·Journal of Neuroinflammation·Nabab KhanXuesong Chen
May 17, 2013·The Journal of Biological Chemistry·Sonia MediouniErwann P Loret
Aug 15, 2021·Archives of Virology·Barbara EnsoliAurelio Cafaro

❮ Previous
Next ❯

Related Concepts

Related Feeds

ASBMB Publications

The American Society for Biochemistry and Molecular Biology (ASBMB) includes the Journal of Biological Chemistry, Molecular & Cellular Proteomics, and the Journal of Lipid Research. Discover the latest research from ASBMB here.

Antibody Specificity

Antibodies produced by B cells are highly specific for antigen as a result of random gene recombination and somatic hypermutation and affinity maturation. As the main effector of the humoral immune system, antibodies can neutralize foreign cells. Find the latest research on antibody specificity here.